Recruiting Neuroendocrine Tumors Studies in Philadelphia
CapTemY90 for Grade 2/3 NET Liver Metastases
This is a Phase 2 evaluation of hepatic-progression free survival among patients with Grade 2 liver-dominant NET metastases undergoing combination therapy with CapTem and Y90 radioembolization.The hyp...
SPEARHEAD-3 Pediatric Study
This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....
About Neuroendocrine Tumors Clinical Trials in Philadelphia
Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.
There are currently 2 neuroendocrine tumors clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 90 participants. Research is being sponsored by Abramson Cancer Center at Penn Medicine, Adaptimmune. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuroendocrine Tumors Clinical Trials in Philadelphia — FAQ
Are there neuroendocrine tumors clinical trials in Philadelphia?
Yes, there are 2 neuroendocrine tumors clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What neuroendocrine tumors treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.
Data updated March 2, 2026 from ClinicalTrials.gov